Consequently, albumin levels emerge as a biologically plausible biomarker that can simultaneously indicate the nutritional and inflammatory status of cancer patients, in whom lower albumin levels may signal a more progressed cancer stage and a poorer prognosis. The gene discussed is ALB; the disease is cancer.